Akar Joseph G, Al-Chekakie M Obadah, Fugate Tyler, Moran Lynn, Froloshki Borislav, Varma Niraj, Santucci Peter, Wilber David J, Matsumura Martin E
Department of Medicine, Division of Cardiology, Loyola University Medical Center, Maywood, Illinois 60153, USA.
Heart Rhythm. 2008 Sep;5(9):1229-35. doi: 10.1016/j.hrthm.2008.05.027. Epub 2008 Jul 23.
The presence of endothelial dysfunction is associated with increased heart failure mortality. Cardiac resynchronization therapy (CRT) improves heart failure outcomes; however, current guidelines do not adequately identify responders to CRT.
The purpose of this study was to determine whether endothelial dysfunction can predict response to CRT.
Brachial artery flow-mediated dilation, a measure of endothelial function, was measured at baseline preimplant and 90 days postimplant in 33 patients undergoing CRT (age 64.2 +/- 16.8 years, left ventricular ejection fraction [LVEF] 25% +/- 9%, QRS duration 158 +/- 25 ms, New York Heart Association class III-IV).
Of the 33 patients, 19 (58%) were responders to CRT. Baseline flow-mediated dilation was 4.6% +/- 4.5% in responders and 8.6% +/- 4.2% in nonresponders (P <.01). After 90 days of CRT, responders had significant improvement in LVEF (23% +/- 8% to 30% +/- 9%, P = .03), 6-minute walk distance (756 +/- 213 feet to 1,089 +/- 242 feet, P = .04), and quality of life (52 +/- 22 to 31 +/- 28, P <.005), whereas nonresponders did not show improvement in these measures. The presence of baseline endothelial dysfunction correlated with impaired baseline functional capacity (r = 0.39, P = .03), and improvement in flow-mediated dilation correlated with improvement in 6-minute walk distance (r = 0.34, P = .05). Logistic regression analysis showed that every 1% reduction in baseline flow-mediated dilation correlated with an approximately 5% increased likelihood of response to CRT. The predictive value of baseline endothelial dysfunction was independent of QRS duration, LVEF, or dyssynchrony and provided additive prognostic value.
The presence of endothelial dysfunction independently identifies CRT responders and provides additive prognostic value for predicting response over current criteria. Addition of endothelial function assessment to current selection criteria may improve the ability to identify CRT responders.
内皮功能障碍的存在与心力衰竭死亡率增加相关。心脏再同步治疗(CRT)可改善心力衰竭的预后;然而,目前的指南并未充分识别出CRT的反应者。
本研究的目的是确定内皮功能障碍是否能预测CRT的反应。
对33例接受CRT治疗的患者(年龄64.2±16.8岁,左心室射血分数[LVEF]25%±9%,QRS时限158±25毫秒,纽约心脏协会心功能分级III-IV级)在植入前基线和植入后90天测量肱动脉血流介导的舒张功能,这是一种内皮功能的测量方法。
33例患者中,19例(58%)为CRT反应者。反应者的基线血流介导的舒张功能为4.6%±4.5%,无反应者为8.6%±4.2%(P<0.01)。CRT治疗90天后,反应者的LVEF有显著改善(从23%±8%提高到30%±9%,P=0.03),6分钟步行距离(从756±213英尺提高到1089±242英尺,P=0.04),以及生活质量(从52±22提高到31±28,P<0.005),而无反应者在这些指标上没有改善。基线内皮功能障碍的存在与基线功能能力受损相关(r=0.39,P=0.03),血流介导的舒张功能改善与6分钟步行距离改善相关(r=0.34,P=0.05)。逻辑回归分析显示,基线血流介导的舒张功能每降低1%,与CRT反应可能性增加约5%相关。基线内皮功能障碍的预测价值独立于QRS时限、LVEF或不同步性,并提供额外的预后价值。
内皮功能障碍的存在可独立识别CRT反应者,并为预测反应提供超过当前标准的额外预后价值。在当前选择标准中增加内皮功能评估可能会提高识别CRT反应者的能力。